By Global Health Security Team

New data show the risk of a serious blood clot from AstraZeneca jab has doubled in a fortnight – but the Government’s regulatory agency has said the benefits still outweigh the risks.

Cases have gone up from 79 to 168 and deaths from 19 to 32, according to the Government’s Yellowcard system which allows people to report vaccine side-effects.

The chance of having a clot has gone from one in 250,000 to one in 126,582.

Rare blood clot events occurred in 93 women and 75 men, aged between 18 and 93, with a case fatality rate of 19 per cent, with 32 deaths.

“On the basis of this ongoing review, the advice remains that the benefits of the vaccine outweigh the risks in the majority of people,” the MHRA has said.

It comes as new figures showed that coronavirus was no longer the leading cause of death in both England and Wales last month for the first time since October.

Elsewhere, universities in the have offered to “hotel quarantine” students from “red listed” India amid concerns the Government will not be able to cope with an influx of up to 50,000 from the country.

Below is a summary of today’s coronavirus-related developments:

  • Another 2,729 cases are confirmed in the UK, while a further 18 deaths take the official tally to 127,345.
  • 432,476 vaccinations were administered yesterday, with 92,703 first doses and 339,773 second doses given.
  • A further 70 cases of the South African variant have been sequenced, as well as another 55 cases of the Indian variant, taking the total to 132. Cases of the P.1 Brazilian variant have risen by 20, to 60.
  • Holiday destinations in up to 30 countries – including Spain’s Canary Islands, Portugal’s Azores and Malta – could make the UK’s green list.
  • Governments within the European Union are preparing a legal case against AstraZenecaover vaccine delivery shortfalls.


Leave a Reply

Your email address will not be published. Required fields are marked *